arrow
N

Nuria Illera

centro de investigación biomédica en red de enfermedades raras
H指数:11
被引数:455

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A Mechanistic Map of the Phenotypic Complexity in Recessive Dystrophic Epidermolysis Bullosa Provides Basis for Therapeutic Target Discovery and Drug Repurposing

隐性营养不良性大疱性表皮松解症的表型复杂性机制图谱为治疗靶点发现和药物重定位提供了基础

2026-09-220
OA
MesenSistem-EB: systemic haploidentical mesenchymal stem cell therapy in recessive dystrophic epidermolysis bullosa associated with clinical benefits and correlated with MCP1 and sCD40L dynamics

MesenSistem-EB:系统性单倍型间充质干细胞疗法在常染色体隐性营养不良性大疱性表皮松解症中的应用,与临床益处相关,并与MCP1和sCD40L动态变化相关

2026-05-050
OA
Unveiling the value of C-reactive protein as a severity biomarker and the IL4/IL13 pathway as a therapeutic target in recessive dystrophic epidermolysis bullosa: A multiparametric cross-sectional study
2024-07-291
OAAI
Gluten-sensitive enteropathy in recessive dystrophic epidermolysis bullosa
2023-09-010
PRE
Evaluation of Systemic Gentamicin as Translational Readthrough Therapy for a Patient With Epidermolysis Bullosa Simplex With Muscular Dystrophy Owing to PLEC1 Pathogenic Nonsense Variants
2022-04-0111
OA
Beneficial Effect of Systemic Allogeneic Adipose Derived Mesenchymal Cells on the Clinical, Inflammatory and Immunologic Status of a Patient With Recessive Dystrophic Epidermolysis Bullosa: A Case Report
2020-11-2611
OAAI
The regenerative potential of fibroblasts in a new diabetes-induced delayed humanised wound healing model

在新的糖尿病诱导的延迟人伤口愈合模型中成纤维细胞的再生潜力

2013-03-1236
OA
Two novel recessive mutations in KRT14 identified in a cohort of 21 Spanish families with epidermolysis bullosa simplex
2011-08-2819
PREAI
The first COL7A1 mutation survey in a large Spanish dystrophic epidermolysis bullosa cohort: c.6527insC disclosed as an unusually recurrent mutation
2010-02-2251
PREAI